No Products in the Cart
Explore why COVID-19 cases are rising this summer and learn about the new FLiRT variants driving the increase. Discover how the Status™ COVID-19/Flu A&B test provides rapid, accurate diagnosis to manage and prevent respiratory illnesses effectively. Stay informed and protect your health.
As summer gatherings kick off, many Americans are finding themselves dealing with COVID-19 once again. Historically, COVID-19 cases have risen during the winter when more people are indoors.
However, this year, cases are also increasing as summer begins, prompting questions about the virus's persistence four years after the pandemic started. Understanding the reasons behind this unexpected rise can help us better prepare and protect ourselves.
Recent data from the Centers for Disease Control and Prevention (CDC) show slight increases in hospitalizations, deaths, and new cases. Although these numbers are not as high as previous peaks, they are a reminder that COVID-19 remains a public health concern.
The current rise in cases, while not alarming, underscores the need for ongoing vigilance and adaptation to new virus patterns.
SARS-CoV-2, the virus causing COVID-19, is constantly mutating to survive and infect more people. These mutations result in new variants and sub-variants, each with unique characteristics. Health experts respond to these changes with updated vaccines and other measures to mitigate the impact on public health. The virus's ability to mutate rapidly is a key factor in its persistence.
The recent increase in cases is driven by a collection of sub-variants known as FLiRT. These variants are derived from the JN.1 variant, a descendant of the omicron variant. FLiRT variants, particularly KP.3, KP.2, and KP.1.1, along with LB.1, have become increasingly prevalent. While these variants are more transmissible, they do not appear to cause more severe illness or different symptoms compared to previous variants.
FLiRT variants may be more transmissible due to mutations that help the virus evade the immune system. According to Andy Pekosz, a professor of molecular biology and immunology at Johns Hopkins Bloomberg School of Public Health, these mutations can make it easier for the virus to avoid antibodies, allowing it to spread more readily.
Michael Osterholm, director of the University of Minnesota’s Center for Infectious Disease Research and Policy, highlights that while there is an increase in cases, the U.S. lacks comprehensive surveillance data this late in the pandemic. This makes it challenging to determine the full extent of the current rise in cases. Wastewater samples, a tool used to monitor COVID-19 spread, indicate increases in virus presence across the U.S.
Typically, respiratory viruses like COVID-19 spread more easily in the winter when people spend more time indoors. However, summer gatherings, travel, and events can also facilitate the spread of the virus. Increased social interactions and reduced adherence to preventive measures during summer months contribute to the rise in cases.
Dr. Jessica Justman, a professor of epidemiology and medicine at Columbia University, explains that the patterns of COVID-19 cases suggest the virus is becoming endemic. This means that COVID-19, like the seasonal flu, will likely continue to circulate at manageable levels rather than disappearing entirely.
Vaccines remain a critical tool in protecting against COVID-19. Although immunity from vaccines can wane over time, they continue to reduce the risk of severe illness. The most recent vaccine update targeted the XBB.1.5 variant, and a new round of vaccines is expected in late summer or early fall to address the JN.1 lineage. Vaccination, including boosters, is especially important for high-risk individuals.
The CDC advises individuals, especially those 65 and older, to get booster shots to maintain immunity. People experiencing respiratory symptoms should stay home to prevent spreading the virus and consult healthcare providers if they are at serious risk of illness. Additionally, wearing masks and practicing social distancing remain effective ways to reduce transmission.
In the context of rising cases and the importance of timely diagnosis, the Status™ COVID-19/Flu A&B test plays a crucial role. This rapid immunoassay allows for the simultaneous detection and differential diagnosis of SARS-CoV-2, Influenza Type A, and Type B antigens from anterior nasal and nasopharyngeal swab specimens.
Key Benefits:
The Status™ COVID-19/Flu A&B test is essential for clinics, hospitals, and urgent care centers, facilitating quick diagnosis and helping to prevent the spread of respiratory illnesses. By enabling rapid and accurate testing, healthcare providers can make timely decisions and reduce the burden on healthcare systems.
As we navigate this unexpected summer surge in COVID-19 cases, it is essential to stay informed and proactive. Understanding the role of new variants and the importance of vaccination can help us manage and mitigate the impact of the virus. By continuing to follow health guidelines and utilizing updated vaccines, we can protect ourselves and our communities from COVID-19.
What makes the Status™ COVID-19/Flu A&B test different from other tests? The Status™ COVID-19/Flu A&B test stands out for its simultaneous detection capability, high sensitivity and specificity, rapid results, and patient comfort with flocked swabs.
How does the test ensure patient comfort? The test uses flocked nasopharyngeal swabs designed for superior specimen collection and patient comfort, making the process less invasive and more efficient.
Where can the Status™ COVID-19/Flu A&B test be used? This test is ideal for clinics, hospitals, and urgent care centers, facilitating quick and accurate diagnosis in high-demand healthcare settings.
How quickly can results be obtained? Results are visually read in just 15 minutes, allowing for prompt decision-making and treatment initiation.
Explore the advancements in personalized medicine and how the Status™ COVID-19/Flu A&B test can enhance your diagnostic capabilities and patient care.
